Novavax, Inc. (NVAX)
10.46
-0.14
(-1.32%)
USD |
NASDAQ |
Oct 02, 16:00
10.44
-0.02
(-0.19%)
After-Hours: 20:00
Novavax Total Liabilities (Quarterly) : 1.146B for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.146B |
| March 31, 2026 | 1.188B |
| December 31, 2025 | 1.311B |
| September 30, 2025 | 1.337B |
| June 30, 2025 | 1.299B |
| March 31, 2025 | 1.369B |
| December 31, 2024 | 2.227B |
| September 30, 2024 | 2.239B |
| June 30, 2024 | 2.250B |
| March 31, 2024 | 2.221B |
| December 31, 2023 | 2.572B |
| September 30, 2023 | 2.336B |
| June 30, 2023 | 2.440B |
| March 31, 2023 | 2.438B |
| December 31, 2022 | 2.893B |
| September 30, 2022 | 2.833B |
| June 30, 2022 | 3.040B |
| March 31, 2022 | 2.770B |
| December 31, 2021 | 2.928B |
| September 30, 2021 | 2.105B |
| June 30, 2021 | 2.004B |
| March 31, 2021 | 1.569B |
| December 31, 2020 | 955.27M |
| September 30, 2020 | 637.76M |
| June 30, 2020 | 547.88M |
| Date | Value |
|---|---|
| March 31, 2020 | 352.04M |
| December 31, 2019 | 358.97M |
| September 30, 2019 | 354.65M |
| June 30, 2019 | 374.88M |
| March 31, 2019 | 371.90M |
| December 31, 2018 | 375.91M |
| September 30, 2018 | 377.16M |
| June 30, 2018 | 373.51M |
| March 31, 2018 | 375.44M |
| December 31, 2017 | 404.22M |
| September 30, 2017 | 408.23M |
| June 30, 2017 | 414.77M |
| March 31, 2017 | 390.60M |
| December 31, 2016 | 399.85M |
| September 30, 2016 | 409.84M |
| June 30, 2016 | 414.89M |
| March 31, 2016 | 407.07M |
| December 31, 2015 | 93.37M |
| September 30, 2015 | 37.62M |
| June 30, 2015 | 37.10M |
| March 31, 2015 | 39.14M |
| December 31, 2014 | 46.38M |
| September 30, 2014 | 30.86M |
| June 30, 2014 | 30.26M |
| March 31, 2014 | 27.54M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 87.82B |
| Pfizer Inc. | 115.64B |
| Agenus, Inc. | 378.54M |
| Editas Medicine, Inc. | 132.08M |
| Recursion Pharmaceuticals, Inc. | 297.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 955.58M |
| Shareholders Equity (Quarterly) | -190.71M |
| Debt to Equity Ratio | -1.559 |
| Current Ratio | 2.333 |
| Net Debt Paydown Yield | -0.88% |